What is the current Price Target for the Panbela Therapeutics Inc stock?

The average Panbela Therapeutics Inc target price is $510.00. This is 216,737.00% higher than the current stock price. The highest price target is 223,114.29%, the lowest is 214,610.88%. 3 Analysts have issued a price target Panbela Therapeutics Inc 2026 .

How high will the Panbela Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Panbela Therapeutics Inc stock will rise. The performance of stocks, including the Panbela Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Panbela Therapeutics Inc stock today?

The performance of Panbela Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Panbela Therapeutics Inc stock fall?

The decline in Panbela Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Panbela Therapeutics Inc Forecast, price target & analysts

$0.21

13.70% yesterday

Nasdaq, Jul 16, 07:54 pm CET

ISIN

US86664M2061

Symbol

PBLA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts Strategies

Panbela Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Panbela Therapeutics Inc Classifications & Recommendation:

Buy

86%

Hold

14%

Panbela Therapeutics Inc Price Target

Target Price	$510.00
Price	$0.24
Potential	216,737.00% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Panbela Therapeutics Inc 2026 . The average Panbela Therapeutics Inc target price is $510.00. This is 216,737.00% register free of charge higher than the current stock price. The highest price target is $525.00 223,114.29% register free of charge , the lowest is $505.00 214,610.88% register free of charge .
	A rating was issued by 7 analysts: 6 Analysts recommend Panbela Therapeutics Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Panbela Therapeutics Inc stock has an average upside potential 2026 of 216,737.00% register free of charge . Most analysts recommend the Panbela Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '23	2024 Estimates
Earnings Per Share $	-232.43	-5.47
	99.40%	97.65%
P/E		negative

3 Analysts have issued a Panbela Therapeutics Inc forecast for earnings per share. The average Panbela Therapeutics Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2023. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2023	$-232.43	99.40%
2024	$-5.47 97.65% Unlock
2025	$-5.77 5.48% Unlock
2026	$-6.16 6.76% Unlock

Current	-0.03	27.72%
2024	-0.04 22.70% Unlock
2025	-0.04 0.00% Unlock
2026	-0.04 0.00% Unlock

Panbela Therapeutics Inc...

Discover more stocks with a high price target

Novo Nordisk 48.20%

Alibaba Group Holding Ltd 43.21%

Deutsche Telekom 28.22%

Adidas 28.05%

Tencent Holdings Ltd. 25.40%

BioNTech SE - ADR 24.68%

NIO ADR 15.40%

Siemens 14.61%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now